Palisade Bio Inc (PALI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $201.01M
Last updated: Nov 17, 2026 at 11:06 AM ET
Palisade Bio Inc (PALI) Competitors
The companies most similar to Palisade Bio are SAB Biotherapeutics (SABS), Precision BioSciences (DTIL) and Upstream Bio (UPB). By market cap, Palisade Bio ranks 9th of the 13 companies on this page; Nautilus Biotechnology (NAUT) is the largest at $295.50M.
Peer Comparison
PALI's revenue growth of 0.0% is above the peer median of -3.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Palisade Bio (PALI) | $201.01M | N/A | 436.8x | 0.0% | N/A | 0.0% | 0.00% |
| SAB Biotherapeutics Inc (SABS) | $266.66M | N/A | N/A | 0.0% | N/A | -62.4% | 0.00% |
| Precision BioSciences Inc (DTIL) | $288.76M | N/A | 4.4x | -85.6% | -38.3% | 37272.0% | 0.00% |
| Upstream Bio, Inc. (UPB) | $152.38M | N/A | 41.0x | 0.0% | N/A | -42.2% | 0.00% |
| Greenwich Lifesciences Inc (GLSI) | $219.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Bright Minds Biosciences Inc (DRUG) | $227.96M | N/A | N/A | 0.0% | -11.2% | 0.0% | 0.00% |
| Sutro Biopharma (STRO) | $163.03M | N/A | 3.4x | 0.0% | N/A | -6.1% | 0.00% |
| Nautilus Biotechnology Inc (NAUT) | $295.50M | N/A | 630.2x | 0.0% | N/A | 0.0% | 0.00% |
| Korro Bio, Inc. (KRRO) | $186.81M | N/A | 175.8x | 0.0% | -82.8% | -43.1% | 0.00% |
| Lineage Cell Therapeutics Inc (LCTX) | $231.35M | N/A | 18.7x | 16.2% | -6.7% | -61.0% | 0.00% |
| Q32 Bio Inc (QTTB) | $260.64M | 2.5x | 5.2x | 60.0% | N/A | 0.0% | 0.00% |
| Sol Gel Technologies Ltd (SLGL) | $180.46M | N/A | 125.4x | 0.0% | N/A | -96.6% | 0.00% |
| Bicycle Therapeutics Ltd (BCYC) | $236.22M | N/A | 2.7x | -169.8% | N/A | 190.2% | 0.00% |
| Peer median | $229.66M | 2.5x | 18.7x | 0.0% | -24.7% | -3.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Palisade Bio, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| SAB Biotherapeutics Inc (SABS) | SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. | SABS competitors |
| Precision BioSciences Inc (DTIL) | Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. | DTIL competitors |
| Upstream Bio, Inc. (UPB) | Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. | UPB competitors |
| Greenwich Lifesciences Inc (GLSI) | Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 /... | GLSI competitors |
| Bright Minds Biosciences Inc (DRUG) | Bright Minds Biosciences Inc. (DRUG) is a forward-thinking clinical-stage biotechnology firm specializing in the development of groundbreaking therapies... | DRUG competitors |
| Sutro Biopharma (STRO) | Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. | STRO competitors |
| Nautilus Biotechnology Inc (NAUT) | Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome... | NAUT competitors |
| Korro Bio, Inc. (KRRO) | Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare... | KRRO competitors |
| Lineage Cell Therapeutics Inc (LCTX) | Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment... | LCTX competitors |
| Q32 Bio Inc (QTTB) | Q32 Bio Inc. (QTTB) is a pioneering biotechnology firm focused on the development of advanced antibody-based therapies for autoimmune diseases and immune... | QTTB competitors |
| Sol Gel Technologies Ltd (SLGL) | Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological... | SLGL competitors |
| Bicycle Therapeutics Ltd (BCYC) | Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. | BCYC competitors |
Frequently Asked Questions About PALI
Who are Palisade Bio's main competitors?
The companies most similar to Palisade Bio include SAB Biotherapeutics (SABS), Precision BioSciences (DTIL), Upstream Bio (UPB), Greenwich Lifesciences (GLSI) and Bright Minds Biosciences (DRUG), listed from the closest match.
Who is Palisade Bio's biggest competitor?
Nautilus Biotechnology (NAUT) is the largest of the similar companies at $295.50M; SAB Biotherapeutics (SABS) is the closest match by business profile, size, sector and industry.
How does PALI stock compare with its competitors?
PALI's P/S is 436.8x against a peer median of 18.7x; its net margin is 0.0% against a peer median of 0.0%.
Which of Palisade Bio's competitors pays a higher dividend?
Palisade Bio pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Palisade Bio bigger than its competitors?
No. Palisade Bio is 9th by market cap among the 13 companies on this page; the largest is Nautilus Biotechnology (NAUT) at $295.50M.
PALI pages: Overview, Earnings, Forecast, Financials, Competitors